About this document
PD-1/PD-L1 Pathway in Cancer Therapy by Remona Remora is a document available to read on EtoBox.
This document summarizes research on the PD-1/PD-L1 pathway in cancer immunotherapy. It discusses how PD-1 and PD-L1 act as immune checkpoints that inhibit anti-tumor immune responses. Blocking the PD-1/PD-L1 pathway with immune checkpoint inhibitors can reactivate T cells to more effectively eliminate cancer cells. The review covers the roles of PD-1 and PD-L1 in cancer and their expression mechanisms, as well as the potential of targeting this pathway for novel cancer treatment strategies.
- Author
- Remona Remora
- Language
- EN